AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36111483 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam Tosilate Sedation with Adjuvant Sufentanil
Number of subjects: 0
Study 36111483 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33686708 — intervention group
Group type: EXPERIMENTAL
Intervention: Spoon forceps
Number of subjects: 75
Study 33686708 — intervention group
Group type: EXPERIMENTAL
Intervention: Alligator forceps
Number of subjects: 75
Study 33686708 — intervention group
Group type: EXPERIMENTAL
Intervention: Snake forceps
Number of subjects: 75
Study 32521309 — intervention group
Group type: EXPERIMENTAL
Intervention: Actionable findings in radiology reports
Number of subjects: 1000
Study 32521309 — intervention group
Group type: EXPERIMENTAL
Intervention: Interannotator agreement
Number of subjects: 1000
Study 36316921 — intervention group
Group type: EXPERIMENTAL
Intervention: Wuwei Fuzheng Yijing formula (WFY)
Number of subjects: 100
Study 36316921 — intervention group
Group type: COMPARATOR
Intervention: Levocarnitine oral solution
Number of subjects: 100
Study 32209700 — intervention group
Group type: COMPARATOR
Intervention: Infancy-onset dietary intervention based on Nordic Nutrition Recommendations, aiming for a dietary fat distribution with a ratio of saturated fatty acids to monounsaturated and polyunsaturated fatty acids of <1:2 and saturated fatty acids intake of <10% of energy intake.
Number of subjects: 2350
Study 32209700 — intervention group
Group type: COMPARATOR
Intervention: Achieving the main intervention target of dietary guidelines.
Number of subjects: 2350
Study 34821431 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 80
Study 34821431 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 80
Study 32253392 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezoelectric technique for third molar root extraction
Number of subjects: 50
Study 32253392 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique using manual and rotary instruments
Number of subjects: 50
Study 33377998 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-tailored print communication (TPC) letters, n = 405
Number of subjects: 1629
Study 33377998 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone motivational interviewing (TMI) sessions, n = 407
Number of subjects: 1629
Study 33377998 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention (two TPC letters and two TMI sessions), n = 408
Number of subjects: 1629
Study 33377998 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group), n = 409
Number of subjects: 1629
Study 33377998 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-tailored print communication (TPC) for fruit and vegetable consumption
Number of subjects: 1629
Study 33377998 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone motivational interviewing (TMI) for fruit and vegetable consumption
Number of subjects: 1629
Study 33106414 — intervention group
Group type: EXPERIMENTAL
Intervention: Training teachers to assess children’s numerical skills every 10 weeks, with adaptive difficulty based on age and skills.
Number of subjects: 49
Study 33106414 — intervention group
Group type: EXPERIMENTAL
Intervention: Training teachers to assess children’s verbal comprehension skills every 10 weeks, with adaptive difficulty based on age and skills.
Number of subjects: 49
Study 33106414 — intervention group
Group type: COMPARATOR
Intervention: Control classrooms with no specific intervention.
Number of subjects: 49
Study 35291989 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 63
Study 35291989 — intervention group
Group type: COMPARATOR
Intervention: Propofol (Control)
Number of subjects: 63
Study 33846516 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster Sets (CS: n=8)
Number of subjects: 24
Study 33846516 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Sets (TS: n=8)
Number of subjects: 24
Study 33846516 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG: n=8)
Number of subjects: 24
Study 32057960 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib cream (1.5% twice daily)
Number of subjects: 307
Study 32057960 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (twice daily)
Number of subjects: 307
Study 32057960 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone cream (0.1% twice daily for 4 weeks then vehicle for 4 weeks)
Number of subjects: 307
Study 35134093 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-tasking (two in parallel)
Number of subjects: 192
Study 35134093 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-tasking (one as interruption)
Number of subjects: 192
Study 35134093 — intervention group
Group type: EXPERIMENTAL
Intervention: Multitasking
Number of subjects: 192
Study 35134093 — intervention group
Group type: COMPARATOR
Intervention: Single-tasking
Number of subjects: 192
Study 35134093 — intervention group
Group type: COMPARATOR
Intervention: Passive control
Number of subjects: 192
Study 33229929 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of lipoprotein (a) [Lp(a)]
Number of subjects: 0
Study 33229929 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated levels of lipoprotein (a) [Lp(a)]
Number of subjects: 0
Study 33229929 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of lipoprotein (a) [Lp(a)]
Number of subjects: 0
Study 35041780 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced multielectrolyte solution (BMES)
Number of subjects: 5037
Study 35041780 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 5037
Study 34292846 — intervention group
Group type: EXPERIMENTAL
Intervention: CME module 1
Number of subjects: 0
Study 34292846 — intervention group
Group type: EXPERIMENTAL
Intervention: CME module 2
Number of subjects: 0
Study 32678055 — intervention group
Group type: EXPERIMENTAL
Intervention: Core decompression (CD) + bone marrow buffy coat (BBC) grafting
Number of subjects: 43
Study 32678055 — intervention group
Group type: COMPARATOR
Intervention: Core decompression (CD)
Number of subjects: 43
Study 34158140 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 74
Study 32785583 — intervention group
Group type: EXPERIMENTAL
Intervention: High-status women
Number of subjects: 55
Study 34582427 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous EEG (30‐48 hr; n = 182)
Number of subjects: 364
Study 34582427 — intervention group
Group type: COMPARATOR
Intervention: Routine EEG (repeated 20‐minute; n = 182)
Number of subjects: 364
Study 34635771 — intervention group
Group type: EXPERIMENTAL
Intervention: SnMP 3.0 mg/kg
Number of subjects: 91
Study 34635771 — intervention group
Group type: EXPERIMENTAL
Intervention: SnMP 4.5 mg/kg
Number of subjects: 91
Study 34635771 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Ctrl)
Number of subjects: 91
Study 32980788 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time video counselling
Number of subjects: 0
Study 32980788 — intervention group
Group type: COMPARATOR
Intervention: Telephone counselling
Number of subjects: 0
Study 35460295 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (16 mg for 4 days, then 24 mg 1½ h before exercise)
Number of subjects: 12
Study 35460295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 33875485 — intervention group
Group type: EXPERIMENTAL
Intervention: icodec LD
Number of subjects: 154
Study 33875485 — intervention group
Group type: EXPERIMENTAL
Intervention: icodec NLD
Number of subjects: 154
Study 33875485 — intervention group
Group type: COMPARATOR
Intervention: IGlar U100
Number of subjects: 154
Study 34499218 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth movement supplemented with micro-osteoperforations (MOPs) (Tr2, n=8)
Number of subjects: 15
Study 34499218 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth movement only (Tr1, n=7)
Number of subjects: 15
Study 34499218 — intervention group
Group type: COMPARATOR
Intervention: Control group (Unt, n=15)
Number of subjects: 15
Study 32869587 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaoli Piwei needling technique (acupuncture for regulating spleen and stomach), once a day for 4 weeks.
Number of subjects: 128
Study 32869587 — intervention group
Group type: COMPARATOR
Intervention: Mosapride citrate dispersible tablet 5 mg, orally 3 times a day for 4 weeks.
Number of subjects: 128
Study 35710339 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated glucose control system
Number of subjects: 105
Study 35710339 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 105
Study 33931347 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal physical therapy intervention
Number of subjects: 31
Study 36370146 — intervention group
Group type: EXPERIMENTAL
Intervention: mAFA intervention
Number of subjects: 1163
Study 36370146 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 1163
Study 35598136 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurological disorders in pregnancy (including primary headache, secondary headache, neurological low back pain, epilepsy, cerebrovascular disorders, peripheral neuropathy, other disorders)
Number of subjects: 91
Study 35598136 — intervention group
Group type: COMPARATOR
Intervention: Control group (91 subjects without neurological disorders)
Number of subjects: 91
Study 36282186 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab (15-100 mg)
Number of subjects: 72
Study 36282186 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab (21-140 mg)
Number of subjects: 72
Study 36334181 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus preferred music listening
Number of subjects: 24
Study 36334181 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus Melomics-Health music listening
Number of subjects: 24
Study 36334181 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 24
Study 33268345 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA class II matching
Number of subjects: 1133
Study 33268345 — intervention group
Group type: COMPARATOR
Intervention: Control group (HLA class II mismatching)
Number of subjects: 1133
Study 34449939 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 278
Study 34449939 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 278
Study 34154178 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization of detector roles as a countermeasure against eavesdropping attacks.
Number of subjects: 0
Study 34154178 — intervention group
Group type: COMPARATOR
Intervention: Generalized attack strategy by eavesdropper (Eve).
Number of subjects: 0
Study 35681986 — intervention group
Group type: EXPERIMENTAL
Intervention: Desk + Program
Number of subjects: 95
Study 35681986 — intervention group
Group type: EXPERIMENTAL
Intervention: Program Only
Number of subjects: 95
Study 35681986 — intervention group
Group type: COMPARATOR
Intervention: Desk Only
Number of subjects: 95
Study 34650017 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual K-file
Number of subjects: 40
Study 34650017 — intervention group
Group type: EXPERIMENTAL
Intervention: One G rotary file
Number of subjects: 40
Study 34650017 — intervention group
Group type: EXPERIMENTAL
Intervention: WaveOne Gold Glider
Number of subjects: 40
Study 34650017 — intervention group
Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 40
Study 36414206 — intervention group
Group type: EXPERIMENTAL
Intervention: digital cognitive behavior therapy (dCBT)
Number of subjects: 90
Study 36414206 — intervention group
Group type: COMPARATOR
Intervention: waitlist control group
Number of subjects: 90
Study 33618146 — intervention group
Group type: EXPERIMENTAL
Intervention: Buddhist walking meditation (BWM) program
Number of subjects: 48
Study 33618146 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise program
Number of subjects: 48
Study 34636066 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke Sense Urbanova app
Number of subjects: 67
Study 34636066 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke Sense Urbanova Plus app
Number of subjects: 67
Study 34636066 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 67
Study 32202265 — intervention group
Group type: EXPERIMENTAL
Intervention: CGly, 800 mg kg‐1
Number of subjects: 32
Study 35108727 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled virus-specific T cells (VSTs)
Number of subjects: 23
Study 35277322 — intervention group
Group type: EXPERIMENTAL
Intervention: Athero-occlusive disease (AOD) present
Number of subjects: 131
Study 35277322 — intervention group
Group type: COMPARATOR
Intervention: No athero-occlusive disease (AOD)
Number of subjects: 131
Study 33786648 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot Ethanolic Propolis extract
Number of subjects: 120
Study 33786648 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 120
Study 33786648 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Ethanolic Propolis extract
Number of subjects: 120
Study 35837991 — intervention group
Group type: EXPERIMENTAL
Intervention: empagliflozin 10 mg
Number of subjects: 23
Study 35837991 — intervention group
Group type: COMPARATOR
Intervention: glimepiride 2 mg
Number of subjects: 23
Study 34224590 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions that included an autonomy component
Number of subjects: 2002
Study 34224590 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 2002
Study 32578332 — intervention group
Group type: EXPERIMENTAL
Intervention: TUEB (hexaminolevulinate-guided transurethral en bloc submucosal hydrodissection)
Number of subjects: 115
Study 32578332 — intervention group
Group type: COMPARATOR
Intervention: TURBT (conventional hexaminolevulinate-guided transurethral resection of bladder tumour)
Number of subjects: 115
Study 32578332 — intervention group
Group type: EXPERIMENTAL
Intervention: TUEB
Number of subjects: 115
Study 32578332 — intervention group
Group type: COMPARATOR
Intervention: TURBT
Number of subjects: 115
Study 35183773 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab with antibiotic use
Number of subjects: 4458
Study 35183773 — intervention group
Group type: COMPARATOR
Intervention: Atezolizumab without antibiotic use
Number of subjects: 4458
Study 35183773 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab with PPI use
Number of subjects: 4458
Study 35183773 — intervention group
Group type: COMPARATOR
Intervention: Atezolizumab without PPI use
Number of subjects: 4458
Study 33404156 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated theoretical model-based intervention
Number of subjects: 0
Study 33404156 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32598217 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia sac disconnection (Group A)
Number of subjects: 34
Study 32598217 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic hernia sac disconnection with peritoneal closure (Group B)
Number of subjects: 34
Study 35666229 — intervention group
Group type: EXPERIMENTAL
Intervention: mFOLFOXIRI plus panitumumab
Number of subjects: 435
Study 35666229 — intervention group
Group type: COMPARATOR
Intervention: Modified FOLFOX plus panitumumab
Number of subjects: 435
Study 32321767 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with cisplatin and gemcitabine
Number of subjects: 107
Study 32321767 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiation
Number of subjects: 107
Study 32321767 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 107
Study 35297493 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 inhibitors (e.g., Tocilizumab)
Number of subjects: 0
Study 35297493 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed seroconversion subgroup
Number of subjects: 0
Study 34154931 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 500
Study 34154931 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical examination
Number of subjects: 500
Study 34154931 — intervention group
Group type: COMPARATOR
Intervention: Incorrect rotation of sites
Number of subjects: 500
Study 34154931 — intervention group
Group type: COMPARATOR
Intervention: Insulin syringe reusage for more than five times
Number of subjects: 500
Study 34154931 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin biopsy
Number of subjects: 500
Study 32109313 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine in conjunction with morphine
Number of subjects: 50
Study 32109313 — intervention group
Group type: COMPARATOR
Intervention: Standard morphine equivalent therapy alone
Number of subjects: 50
Study 35794395 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help parenting program with biweekly telephonic support
Number of subjects: 110
Study 35794395 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help parenting program without biweekly telephonic support
Number of subjects: 110
Study 35794395 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 110
Study 33587120 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal TSH (per 1 SD increase)
Number of subjects: 0
Study 33587120 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal FT4 (per 1 SD increase)
Number of subjects: 0
Study 33399632 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of 100,000 IU of vitamin D (SG)
Number of subjects: 84
Study 33399632 — intervention group
Group type: COMPARATOR
Intervention: Daily oral doses of 400 IU of vitamin D (CG)
Number of subjects: 84
Study 35365179 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg alemtuzumab
Number of subjects: 23
Study 35365179 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg alemtuzumab
Number of subjects: 23
Study 33880019 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized glycopyrrolate (GLY) 25 ?g twice-daily (BID)
Number of subjects: 861
Study 33880019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 861
Study 33498955 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-hour time-restricted eating (TRE) over a 12-week monitored intervention followed by a 12-week self-directed intervention
Number of subjects: 0
Study 33498955 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-hour time-restricted eating (TRE)
Number of subjects: 0
Study 35300507 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-lecture education
Number of subjects: 100
Study 35300507 — intervention group
Group type: COMPARATOR
Intervention: Traditional cardiac rehabilitation education
Number of subjects: 100
Study 32681596 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg·kg‐1)
Number of subjects: 15
Study 32681596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 35700915 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS-real
Number of subjects: 27
Study 35700915 — intervention group
Group type: COMPARATOR
Intervention: rTMS-sham
Number of subjects: 27
Study 36172943 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcarotid artery revascularization (TCAR)
Number of subjects: 118566
Study 36172943 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 118566
Study 36172943 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral carotid artery stenting (TF-CAS)
Number of subjects: 118566
Study 34035087 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted training plus usual care
Number of subjects: 770
Study 34035087 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced upper limb therapy (EULT) programme plus usual care
Number of subjects: 770
Study 34035087 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 770
Study 33132076 — intervention group
Group type: EXPERIMENTAL
Intervention: Education program for hemodialysis patients
Number of subjects: 50
Study 33132076 — intervention group
Group type: COMPARATOR
Intervention: No education program (control group)
Number of subjects: 50
Study 34264757 — intervention group
Group type: EXPERIMENTAL
Intervention: Play and Learn for Surgeons (PLS) game
Number of subjects: 46
Study 34264757 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 46
Study 32402223 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaired cleft palate with VPI
Number of subjects: 15
Study 32402223 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaired cleft palate with complete velopharyngeal closure
Number of subjects: 15
Study 32402223 — intervention group
Group type: COMPARATOR
Intervention: Noncleft anatomy
Number of subjects: 15
Study 32402223 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 15
Study 36375378 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load resistance training
Number of subjects: 37
Study 36375378 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load resistance training
Number of subjects: 37
Study 36375378 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study 34134724 — intervention group
Group type: EXPERIMENTAL
Intervention: Practitioner-led referral
Number of subjects: 500
Study 34134724 — intervention group
Group type: EXPERIMENTAL
Intervention: Researcher-led recruitment
Number of subjects: 500
Study 34134724 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-referral
Number of subjects: 500
Study 34134724 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recruitment
Number of subjects: 500
Study 34134724 — intervention group
Group type: EXPERIMENTAL
Intervention: Research nurse referrals
Number of subjects: 500
Study 34134724 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist midwives referrals
Number of subjects: 500
Study 34134724 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of recruitment
Number of subjects: 500
Study 32933489 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic fast-track transition to specialised palliative care (SPC) enriched with a psychological intervention at home
Number of subjects: 321
Study 32933489 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 321
Study 35185122 — intervention group
Group type: COMPARATOR
Intervention: Nitinol Stent (NS)
Number of subjects: 209
Study 35185122 — intervention group
Group type: EXPERIMENTAL
Intervention: Vein Bypass (VBP)
Number of subjects: 209